PAVmed Inc. Files 424B3 Prospectus
Ticker: PAVM · Form: 424B3 · Filed: Apr 29, 2026 · CIK: 0001624326
| Field | Detail |
|---|---|
| Company | Pavmed Inc. (PAVM) |
| Form Type | 424B3 |
| Filed Date | Apr 29, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus, securities-offering, filing
Related Tickers: PAVM
TL;DR
PAVM filed a prospectus (424B3) on 4/29/26. Expecting capital raise.
AI Summary
PAVmed Inc. filed a 424B3 prospectus on April 29, 2026, detailing its offerings. The filing, with SEC Accession No. 0001493152-26-019594, provides information related to securities offerings. The company's mailing and business address is 360 Madison Avenue, 25th Floor, New York, NY 10017.
Why It Matters
This filing indicates PAVmed Inc. is actively engaging in securities offerings, which could impact its capital structure and future operations.
Risk Assessment
Risk Level: medium — Prospectus filings can indicate potential dilution or capital raising activities, which carry inherent risks for investors.
Key Numbers
- 2026-04-29 — Filing Date (Date PAVmed Inc. filed the 424B3 prospectus)
Key Players & Entities
- PAVmed Inc. (company) — Filer of the 424B3 prospectus
- 0001493152-26-019594 (filing_id) — SEC Accession Number for the 424B3 filing
- 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 (address) — Mailing and Business Address for PAVmed Inc.
FAQ
What is the purpose of a 424B3 filing?
A 424B3 filing is a prospectus supplement used to describe additional securities being offered or to update information previously filed.
What is PAVmed Inc.'s business?
PAVmed Inc. is involved in Surgical & Medical Instruments & Apparatus, as indicated by its SIC code.
When was this filing accepted by the SEC?
The filing was accepted on April 29, 2026, at 16:15:23.
What is the CIK number for PAVmed Inc.?
The CIK number for PAVmed Inc. is 0001624326.
What is the state of incorporation for PAVmed Inc.?
PAVmed Inc. is incorporated in Delaware (DE).
Filing Details
This Form 424B3 (Form 424B3) was filed with the SEC on April 29, 2026 regarding PAVmed Inc. (PAVM).